ReviewCancers2022

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review.

Biagio Barone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.